Actively Recruiting
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
Led by University of Maryland, Baltimore · Updated on 2025-07-23
20
Participants Needed
1
Research Sites
369 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a two-tiered pilot study in which there will be no randomization and no placebo treatment. This study will be to perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population
CONDITIONS
Official Title
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 40 and less than 80 years
- Clinical suspicion or history of prostate cancer with one of the following: PSA > 4 ng/ml, abnormal DRE exam, or known tissue diagnosis of prostate cancer
- Planning to undergo MRI-targeted biopsy or radical prostatectomy for prostate cancer evaluation or treatment
You will not qualify if you...
- Unable to undergo MRI scan
- Unable to receive intravenous contrast according to institutional guidelines
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Maryland Medical Center
Baltimore, Maryland, United States, 21201
Actively Recruiting
Research Team
M
Minhaj Siddiqui, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here